Field Medical Science Liaison – Rare Diseases (Liver Focus)

Mirum Pharmaceuticals, Inc.; Boston (MA); Remote; USD 140,000 - 185,000; Full time

Job summary

Mirum Pharmaceuticals is seeking a field-based Medical Science Liaison to establish and maintain relationships with thought leaders and healthcare professionals in the New England area. You will support the rare disease liver portfolio and engage in scientific exchange, advisory boards, and cross-collaborative initiatives.

The role requires advancing scientific knowledge, communicating complex information clearly, and traveling up to 60% to meet with investigators and stakeholders.

Qualifications

• Advanced science or clinical degree required.
• 5+ years field MSL experience preferred.
• Rare disease experience or hepatology/gastroenterology familiarity preferred.
• Willingness to travel up to 60%.

Responsibilities

• Identify and develop professional relationships with thought leaders and healthcare professionals within assigned geography.
• Support research initiatives and provide support to clinical site investigators.
• Serve as liaison for investigator-initiated research proposals and reviews.
• Engage in scientific exchange in response to HCP requests and present data to diverse audiences.
• Stay abreast of emerging literature and clinical data to support the portfolio.
• Assist in advisory boards and congress/conference strategy with scientific insights.

Skills

Scientific communication

KOL relationship management

Clinical trial support

Travel readiness

MS Office proficiency

Education

Advanced science or clinical degree (MD, DO, Pharm.D., PhD, NP, PA)

Tools

MS Office

Job description

Mirum Pharmaceuticals is seeking a field-based Medical Science Liaison to establish and maintain relationships with thought leaders and healthcare professionals in the New England area. You will support the rare disease liver portfolio and engage in scientific exchange, advisory boards, and cross-collaborative initiatives.

The role requires advancing scientific knowledge, communicating complex information clearly, and traveling up to 60% to meet with investigators and stakeholders.